scispace - formally typeset
B

Barbara U. Schraml

Researcher at Ludwig Maximilian University of Munich

Publications -  43
Citations -  6149

Barbara U. Schraml is an academic researcher from Ludwig Maximilian University of Munich. The author has contributed to research in topics: Dendritic cell & Medicine. The author has an hindex of 19, co-authored 34 publications receiving 5116 citations. Previous affiliations of Barbara U. Schraml include London Research Institute & Francis Crick Institute.

Papers
More filters
Book ChapterDOI

Tissue-Specific Diversity and Functions of Conventional Dendritic Cells.

TL;DR: The diversity of DC subtypes found across tissues are reviewed and the current understanding of the tissue-specific functions of these cell types are discussed.
Journal ArticleDOI

Clec9a-Mediated Ablation of Conventional Dendritic Cells Suggests a Lymphoid Path to Generating Dendritic Cells In Vivo.

TL;DR: It is suggested that the lymphoid lineage can generate cells with features of cDCs when myeloid cDC progenitors are impaired, and this study crosses Clec9a-Cre mice to Rosa-lox-STOP- lox-diphtheria toxin mice to reveal a previously unappreciated developmental heterogeneity of c DCs.
Journal ArticleDOI

A complement receptor for opsonized immune complexes on erythrocytes from Oncorhynchus mykiss but not Ictalarus punctatus.

TL;DR: Investigating whether a complement-dependent immune adherence receptor is expressed on erythrocytes from the rainbow trout and the channel catfish suggests that differences exist in receptor distribution between two closely related species of fish, and a potentially homologous relationship in receptor expression, and possibility function, exist between two highly divergent species.
Journal ArticleDOI

Understanding the Functional Properties of Neonatal Dendritic Cells: A Doorway to Enhance Vaccine Effectiveness?

TL;DR: Some of the unique aspects of neonatal DCs that shape immune responses in early life are reviewed and whether the functional properties of neonnatal DCs could be exploited or manipulated to promote more effective vaccination in earlylife is speculated.